APA (7th ed.) Citation

J, A., M, M., I, A., R, L., M, D. C. M., J, L., . . . I, M. (2021). Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program. Cancer immunology, immunotherapy : CII, 70(11), 3277. https://doi.org/10.1007/s00262-021-02924-5

Chicago Style (17th ed.) Citation

J, Arranz-Nicolás, Martin-Salgado M, Adán-Barrientos I, Liébana R, Del Carmen Moreno-Ortíz M, Leitner J, Steinberger P, Ávila-Flores A, and Merida I. "Diacylglycerol Kinase α Inhibition Cooperates with PD-1-targeted Therapies to Restore the T Cell Activation Program." Cancer Immunology, Immunotherapy : CII 70, no. 11 (2021): 3277. https://doi.org/10.1007/s00262-021-02924-5.

MLA (9th ed.) Citation

J, Arranz-Nicolás, et al. "Diacylglycerol Kinase α Inhibition Cooperates with PD-1-targeted Therapies to Restore the T Cell Activation Program." Cancer Immunology, Immunotherapy : CII, vol. 70, no. 11, 2021, p. 3277, https://doi.org/10.1007/s00262-021-02924-5.